NCT01524926 2023-12-11CREATEEuropean Organisation for Research and Treatment of Cancer - EORTCPhase 2 Completed582 enrolled
NCT02134912 2020-02-20S1300: Pemetrexed Disodium With or Without Crizotinib in Treating Patients With Stage IV Non-Small Cell Lung Cancer That Has Progressed After CrizotinibSWOG Cancer Research NetworkPhase 2 Terminated1 enrolled